Several retrospective studies have discovered [2,3,4] that patients with NSCLC harbor different driver mutations (EGFR, BRAF, ROS1, MET, ALK, etc.), among which epidermal growth factor receptor (EGFR) mutations are prevalent. The gene discussed is ALK; the disease is non-small cell lung carcinoma.